FERTIPARIN 60

FERTIPARIN 60

Product Overview

FERTIPARIN 60 is a pharmaceutical preparation used in the management of blood clot-related conditions. It contains low molecular weight heparin (LMWH) as its active ingredient and is prescribed to reduce the risk of thromboembolic events. This medication is used under medical supervision in patients at risk of conditions such as deep vein thrombosis (DVT), pulmonary embolism, or other clotting disorders.

How It Works

The active ingredient, low molecular weight heparin, acts on clotting factors in the blood, particularly Factor Xa and, to a lesser extent, Factor IIa (thrombin). This action is associated with reduced formation of fibrin clots, which are involved in blockage of blood vessels. It is used in maintaining blood flow and in conditions related to thrombosis.

Uses / Indications

FERTIPARIN 60 is indicated for:

• Prevention of deep vein thrombosis (DVT) in patients undergoing surgery or with limited mobility
• Management and prevention of pulmonary embolism
• Use in assisted reproductive treatments under specialist supervision
• Use in clotting-related conditions as advised by a healthcare professional

This medicine should be used only for medically approved indications under the guidance of a healthcare professional.

Composition

• Active Ingredient: Low Molecular Weight Heparin (LMWH)
• Dosage Form: Injectable solution (pre-filled syringes)
• Strength: As determined by the prescribing physician based on patient condition

Administration

FERTIPARIN 60 is administered via subcutaneous injection, typically in the abdominal area or as directed by a healthcare professional. The dose and frequency depend on the patient’s condition. Self-administration should only be done after training. Medical supervision is required.

Storage Instructions

• Store at room temperature (15–25°C) in a cool, dry place
• Protect from direct sunlight and moisture
• Do not freeze
• Keep syringes in original packaging until use
• Dispose of used syringes as per local medical guidelines

Important Information

• Use only under medical supervision
• Patients with bleeding conditions or recent surgery should be monitored
• Hypersensitivity reactions may occur
• Blood tests may be required in some cases
• Use during pregnancy and lactation only if advised by a healthcare professional

External Reference

For more information, refer to:
World Health Organization – Anticoagulant Guidelines